Found: 7
Select item for more details and to access through your institution.
Whole-Body Dosimetry for Individualized Treatment Planning of <sup>131</sup>I-MIBG Radionuclide Therapy for Neuroblastoma.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 9, p. 1518, doi. 10.2967/jnumed.109.064469
- By:
- Publication type:
- Article
Three-Dimensional Dosimetry for Intralesional Radionuclide Therapy Using Mathematical Modeling and Multimodality Imaging.
- Published in:
- Journal of Nuclear Medicine, 1997, v. 38, n. 7, p. 1059
- By:
- Publication type:
- Article
A Phase 1, Open-Label Study of the Biodistribution, Pharmacokinetics, and Dosimetry of <sup>223</sup>Ra-Dichloride in Patients with Hormone-Refractory Prostate Cancer and Skeletal Metastases.
- Published in:
- Journal of Nuclear Medicine, 2015, v. 56, n. 9, p. 1304, doi. 10.2967/jnumed.115.157123
- By:
- Publication type:
- Article
Reply to 'Single high dose versus repeated bone-targeted radionuclide therapy'.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Reply to: Can an undetectable value of TG and a negative neck ultrasound study be considered reliable methods to assess the completeness of thyroid ablation?
- Published in:
- 2010
- By:
- Publication type:
- Letter
A dose-effect correlation for radioiodine ablation in differentiated thyroid cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 2, p. 270, doi. 10.1007/s00259-009-1261-3
- By:
- Publication type:
- Article
A model-based method for the prediction of whole-body absorbed dose and bone marrow toxicity for [sup 186]Re-HEDP treatment of skeletal metastases from prostate cancer.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2003, v. 30, n. 8, p. 1114, doi. 10.1007/s00259-003-1197-y
- By:
- Publication type:
- Article